Related Experiment Video
Updated: Jul 10, 2025
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.4K
Immune Priming with Spatially Fractionated Radiation Therapy.
Lauren Lukas1, Hualin Zhang2, Karen Cheng2
1Department of Radiation Oncology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. llukas@usc.edu.
Current Oncology Reports
|November 18, 2023
Summary
Spatially fractionated radiation therapy (SFRT) shows promise in enhancing cancer immunotherapy by stimulating immune responses. Combining SFRT with immunotherapy may overcome resistance and improve treatment efficacy.
Area of Science:
- Oncology
- Immunology
- Radiation Oncology
Background:
- Cancer immunotherapy efficacy is often limited by immune resistance.
- Radiation therapy can modulate the immune system and potentially synergize with immunotherapy.
- Spatially fractionated radiation therapy (SFRT) is a novel technique with potential immunomodulatory effects.
Purpose of the Study:
- To review preclinical and clinical evidence on the nontargeted immune effects of SFRT.
- To explore strategies for combining SFRT with immunotherapy (IT) to enhance treatment outcomes.
Main Methods:
- Review of existing preclinical and clinical studies on SFRT.
- Analysis of SFRT's mechanisms of action on the immune system.
- Identification of combination strategies with immunotherapy.
Main Results:
- SFRT may enhance antigen presentation and T-cell activation within tumors.
- Heterogeneous dose distribution in SFRT could promote immune cell infiltration.
- SFRT demonstrates potential for synergistic effects when combined with immunotherapy.
Conclusions:
- Understanding SFRT's nontargeted immune effects is crucial for developing novel therapeutic strategies.
- Integrating SFRT with immunotherapy offers an innovative approach to combat immune resistance.
- This combination aims to improve the therapeutic ratio of radiation therapy and boost immunotherapy efficacy.
